IVECO GROUP NV (IVG.MI) Fundamental Analysis & Valuation

BIT:IVG • NL0015000LU4

Current stock price

19.155 EUR
+0.02 (+0.08%)
Last:

This IVG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IVG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year IVG was profitable.
  • In the past year IVG had a positive cash flow from operations.
  • Each year in the past 5 years IVG has been profitable.
  • In the past 5 years IVG always reported a positive cash flow from operatings.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of IVG (1.48%) is comparable to the rest of the industry.
  • IVG's Return On Equity of 10.01% is fine compared to the rest of the industry. IVG outperforms 68.22% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.17%, IVG is in line with its industry, outperforming 42.99% of the companies in the same industry.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 4.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.82%, IVG is doing worse than 61.68% of the companies in the same industry.
  • IVG's Profit Margin has improved in the last couple of years.
  • IVG has a Operating Margin of 4.33%. This is comparable to the rest of the industry: IVG outperforms 42.99% of its industry peers.
  • In the last couple of years the Operating Margin of IVG has grown nicely.
  • The Gross Margin of IVG (16.00%) is worse than 90.65% of its industry peers.
  • IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IVG.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
  • The number of shares outstanding for IVG has been increased compared to 1 year ago.
  • IVG has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IVG has been reduced compared to a year ago.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.75, we must say that IVG is in the distress zone and has some risk of bankruptcy.
  • IVG's Altman-Z score of 1.75 is in line compared to the rest of the industry. IVG outperforms 42.99% of its industry peers.
  • The Debt to FCF ratio of IVG is 9.94, which is on the high side as it means it would take IVG, 9.94 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IVG (9.94) is worse than 62.62% of its industry peers.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that IVG has dependencies on debt financing.
  • IVG has a Debt to Equity ratio of 1.29. This is amonst the worse of the industry: IVG underperforms 81.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.75
ROIC/WACC0.58
WACC7.18%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.91. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a better Current ratio (1.91) than 69.16% of its industry peers.
  • IVG has a Quick Ratio of 1.38. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a Quick ratio of 1.38. This is amongst the best in the industry. IVG outperforms 80.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IVG.MI Growth Analysis

3.1 Past

  • IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.23%.
  • IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.20% yearly.
  • The Revenue has decreased by -8.94% in the past year.
  • Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.22% on average per year.
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%

3.2 Future

  • IVG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.56% yearly.
  • IVG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.98% yearly.
EPS Next Y85.07%
EPS Next 2Y50.34%
EPS Next 3Y47.56%
EPS Next 5YN/A
Revenue Next Year9.13%
Revenue Next 2Y7.59%
Revenue Next 3Y8.98%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. IVG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.51 indicates a correct valuation of IVG.
  • Compared to the rest of the industry, the Price/Earnings ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 75.70% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. IVG is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 8.92, the valuation of IVG can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 90.65% of the companies are valued more expensively.
  • IVG is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.51
Fwd PE 8.92
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than 75.70% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 76.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.84
EV/EBITDA 6.43
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • IVG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IVG's earnings are expected to grow with 47.56% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y50.34%
EPS Next 3Y47.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. IVG.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.72%, IVG has a reasonable but not impressive dividend return.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.49.
  • Compared to an average S&P500 Dividend Yield of 1.89, IVG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 33.46% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP33.46%
EPS Next 2Y50.34%
EPS Next 3Y47.56%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVG.MI Fundamentals: All Metrics, Ratios and Statistics

IVECO GROUP NV

BIT:IVG (3/20/2026, 7:00:00 PM)

19.155

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners35.18%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.20B
Revenue(TTM)13.92B
Net Income(TTM)263.00M
Analysts67.69
Price Target20.11 (4.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend0.26
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.95%
EPS NY rev (3m)-1.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 8.92
P/S 0.36
P/FCF 8.84
P/OCF 3.66
P/B 1.98
P/tB 7.98
EV/EBITDA 6.43
EPS(TTM)1.16
EY6.06%
EPS(NY)2.15
Fwd EY11.21%
FCF(TTM)2.17
FCFY11.32%
OCF(TTM)5.23
OCFY27.31%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)0.19
PEG (5Y)N/A
Graham Number15.9
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 4.17%
ROICexc 5.08%
ROICexgc 6.33%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.75
F-Score6
WACC7.18%
ROIC/WACC0.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)159.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
EPS Next Y85.07%
EPS Next 2Y50.34%
EPS Next 3Y47.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%
Revenue Next Year9.13%
Revenue Next 2Y7.59%
Revenue Next 3Y8.98%
Revenue Next 5YN/A
EBIT growth 1Y-33.08%
EBIT growth 3Y3.22%
EBIT growth 5YN/A
EBIT Next Year125.49%
EBIT Next 3Y46.05%
EBIT Next 5YN/A
FCF growth 1Y93.42%
FCF growth 3Y7.24%
FCF growth 5Y37.52%
OCF growth 1Y12%
OCF growth 3Y-17.96%
OCF growth 5Y6.81%

IVECO GROUP NV / IVG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 5 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 7 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Undervalued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to grow by 85.07% in the next year.